Education
About Us
Working with TipRanks
Follow Us
Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM
AXSM Analyst Ratings
Strong Buy
18 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
AXSM Stock 12 Month Forecast
Average Price Target
$175.87
▲(65.49% Upside)
| Highest Price Target$216.00 | Average Price Target$175.87 | Lowest Price Target$133.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Morgan Stanley
Reiterated
04/25/25
William Blair
Reiterated
04/14/25
H.C. Wainwright
Reiterated
04/03/25
Leerink Partners
Reiterated
04/01/25
Bank of America Securities
Reiterated
04/01/25
Mizuho Securities
Reiterated
04/01/25
Truist Financial
―
Buy
―
Reiterated
03/26/25
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (NASDAQ: AXSM), Acrivon Therapeutics, Inc. (NASDAQ: ACRV) and 3SBio (Other OTC: TRSBF)
Piper Sandler
$148
Buy
39.27%
Upside
Reiterated
03/26/25
Piper Sandler Sticks to Their Buy Rating for Axsome Therapeutics (AXSM)
Wells Fargo
$160
Buy
50.56%
Upside
Reiterated
03/25/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Roche Holding AG (Other OTC: RHHVF), Kezar Life Sciences (NASDAQ: KZR) and Axsome Therapeutics (NASDAQ: AXSM)
TD Cowen
$190
Buy
78.79%
Upside
Reiterated
03/06/25
TD Cowen Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)
Robert W. Baird
$132→$160
Buy
50.56%
Upside
Reiterated
03/03/25
Axsome Therapeutics price target raised to $160 from $132 at BairdAxsome Therapeutics price target raised to $160 from $132 at Baird
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Morgan Stanley
Reiterated
04/25/25
William Blair
Reiterated
04/14/25
H.C. Wainwright
Reiterated
04/03/25
Leerink Partners
Reiterated
04/01/25
Bank of America Securities
Reiterated
04/01/25
Mizuho Securities
Reiterated
04/01/25
Truist Financial
―
Buy
―
Reiterated
03/26/25
Analysts Offer Insights on Healthcare Companies: Axsome Therapeutics (NASDAQ: AXSM), Acrivon Therapeutics, Inc. (NASDAQ: ACRV) and 3SBio (Other OTC: TRSBF)
Piper Sandler
$148
Buy
39.27%
Upside
Reiterated
03/26/25
Piper Sandler Sticks to Their Buy Rating for Axsome Therapeutics (AXSM)
Wells Fargo
$160
Buy
50.56%
Upside
Reiterated
03/25/25
Analysts' Opinions Are Mixed on These Healthcare Stocks: Roche Holding AG (Other OTC: RHHVF), Kezar Life Sciences (NASDAQ: KZR) and Axsome Therapeutics (NASDAQ: AXSM)
TD Cowen
$190
Buy
78.79%
Upside
Reiterated
03/06/25
TD Cowen Reaffirms Their Buy Rating on Axsome Therapeutics (AXSM)
Robert W. Baird
$132→$160
Buy
50.56%
Upside
Reiterated
03/03/25
Axsome Therapeutics price target raised to $160 from $132 at BairdAxsome Therapeutics price target raised to $160 from $132 at Baird
Best Analysts Covering Axsome Therapeutics
Which Analyst Should I Follow If I Want to Buy AXSM and Sell After:
1 Month
xxx
Success Rate
11/18 ratings generated profit
Average Return
-0.64%
reiterated a xxx
rating 4 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 61.11% of your transactions generating a profit, with an average return of -0.64% per trade.
3 Months
xxx
Success Rate
16/23 ratings generated profit
Average Return
+47.28%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 69.57% of your transactions generating a profit, with an average return of +47.28% per trade.
1 Year
Success Rate
13/15 ratings generated profit
Average Return
+23.42%
reiterated a buy rating 26 days ago
Copying Leonid Timashev's trades and holding each position for 1 Year would result in 86.67% of your transactions generating a profit, with an average return of +23.42% per trade.
2 Years
xxx
Success Rate
28/31 ratings generated profit
Average Return
+35.63%
reiterated a xxx
rating 28 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 90.32% of your transactions generating a profit, with an average return of +35.63% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
AXSM Analyst Recommendation Trends
Rating
Dec 24
Jan 25
Feb 25
Mar 25
Apr 25
Strong Buy
13
16
19
20
23
Buy
42
48
55
60
51
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
55
64
74
80
74
Each month's total comprises the sum of three months' worth of ratings.
AXSM Financial Forecast
AXSM Stock Forecast FAQ
What is AXSM’s average 12-month price target, according to analysts?
Based on analyst ratings, Axsome Therapeutics Inc’s 12-month average price target is 175.87.
What is AXSM’s upside potential, based on the analysts’ average price target?
Axsome Therapeutics Inc has 65.49% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is AXSM a Buy, Sell or Hold?
Axsome Therapeutics Inc has a consensus rating of Strong Buy which is based on 18 buy ratings, 0 hold ratings and 0 sell ratings.
What is Axsome Therapeutics Inc’s price target?
The average price target for Axsome Therapeutics Inc is 175.87. This is based on 18 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $216.00 ,the lowest forecast is $133.00. The average price target represents 65.49% Increase from the current price of $106.27.
The highest analyst price target is $216.00 ,the lowest forecast is $133.00. The average price target represents 65.49% Increase from the current price of $106.27.
What do analysts say about Axsome Therapeutics Inc?
Axsome Therapeutics Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 18 Wall Streets Analysts.
How can I buy shares of AXSM?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.